Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas J Scriba

Showing results (31-40 of 263) with videos related to

Pageof 27
Sort By:
Infection and Immunity|October 17, 2007
Use of peptide-major histocompatibility complex tetramer technology to study interactions between Staphylococcus aureus proteins and human cellsRuth C Massey, Thomas J Scriba, Eric L Brown, et al.
Seminars in Respiratory and Critical Care Medicine|August 3, 2018
Diagnostic Challenge of Tuberculosis HeterogeneityElisa Nemes, Erin W Meermeier, Thomas J Scriba, et al.
The Journal of Infectious Diseases|July 25, 2024
Estimating the Potential Public Health Value of BCG RevaccinationRebecca A Clark, Tom Sumner, Chathika K Weerasuriya, et al.
Plos Pathogens|March 5, 2019
A comparison of antigen-specific T cell responses induced by six novel tuberculosis vaccine candidatesMiguel J Rodo, Virginie Rozot, Elisa Nemes, et al.
The Journal of Infectious Diseases|June 2, 2016
Vaccination Against Tuberculosis With Whole-Cell Mycobacterial VaccinesThomas J Scriba, Stefan H E Kaufmann, Paul Henri Lambert, et al.
Infection and Immunity|March 12, 2008
The Staphyloccous aureus Eap protein activates expression of proinflammatory cytokinesThomas J Scriba, Sophie Sierro, Eric L Brown, et al.
AIDS (London, England)|November 1, 2002
African-based CCR5 single-nucleotide polymorphism associated with HIV-1 disease progressionVanessa M Hayes, Desiree C Petersen, Thomas J Scriba, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 28, 2016
BCG and New Preventive Tuberculosis Vaccines: Implications for Healthcare WorkersMark Hatherill, Thomas J Scriba, Zarir F Udwadia, et al.
BMJ Open|August 6, 2021
Host blood transcriptomic biomarkers of tuberculosis disease in people living with HIV: a systematic review protocolSimon C Mendelsohn, Humphrey Mulenga, Stanley Kimbung Mbandi, et al.
Vaccine: X|June 27, 2022
T cell responses to <i>Mycobacterium indicus pranii</i> immunotherapy and adjunctive glucocorticoid therapy in tuberculous pericarditisPia Steigler, Mukesh Chhiba, Veronica Francis, et al.
Pageof 27

Showing results (31-40 of 263) with videos related to

Sort By:
Pageof 27
Infection and Immunity|October 17, 2007
Use of peptide-major histocompatibility complex tetramer technology to study interactions between Staphylococcus aureus proteins and human cellsRuth C Massey, Thomas J Scriba, Eric L Brown, et al.
Seminars in Respiratory and Critical Care Medicine|August 3, 2018
Diagnostic Challenge of Tuberculosis HeterogeneityElisa Nemes, Erin W Meermeier, Thomas J Scriba, et al.
The Journal of Infectious Diseases|July 25, 2024
Estimating the Potential Public Health Value of BCG RevaccinationRebecca A Clark, Tom Sumner, Chathika K Weerasuriya, et al.
Plos Pathogens|March 5, 2019
A comparison of antigen-specific T cell responses induced by six novel tuberculosis vaccine candidatesMiguel J Rodo, Virginie Rozot, Elisa Nemes, et al.
The Journal of Infectious Diseases|June 2, 2016
Vaccination Against Tuberculosis With Whole-Cell Mycobacterial VaccinesThomas J Scriba, Stefan H E Kaufmann, Paul Henri Lambert, et al.
Infection and Immunity|March 12, 2008
The Staphyloccous aureus Eap protein activates expression of proinflammatory cytokinesThomas J Scriba, Sophie Sierro, Eric L Brown, et al.
AIDS (London, England)|November 1, 2002
African-based CCR5 single-nucleotide polymorphism associated with HIV-1 disease progressionVanessa M Hayes, Desiree C Petersen, Thomas J Scriba, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 28, 2016
BCG and New Preventive Tuberculosis Vaccines: Implications for Healthcare WorkersMark Hatherill, Thomas J Scriba, Zarir F Udwadia, et al.
BMJ Open|August 6, 2021
Host blood transcriptomic biomarkers of tuberculosis disease in people living with HIV: a systematic review protocolSimon C Mendelsohn, Humphrey Mulenga, Stanley Kimbung Mbandi, et al.
Vaccine: X|June 27, 2022
T cell responses to <i>Mycobacterium indicus pranii</i> immunotherapy and adjunctive glucocorticoid therapy in tuberculous pericarditisPia Steigler, Mukesh Chhiba, Veronica Francis, et al.
Pageof 27